-
公开(公告)号:US08822437B2
公开(公告)日:2014-09-02
申请号:US13520899
申请日:2011-01-06
申请人: Masataka Ifuku , Takehiko Fujino , Shirou Mawatari , Masaaki Sugiyama , Yoshirou Kodama , Hidetaka Fuchu , Keita Yunoki
发明人: Masataka Ifuku , Takehiko Fujino , Shirou Mawatari , Masaaki Sugiyama , Yoshirou Kodama , Hidetaka Fuchu , Keita Yunoki
CPC分类号: A61K31/685 , A23L33/10 , A61K35/57 , A61K38/12
摘要: An objective of the present invention is to provide a new substance having a cerebral nerve cell neogenesis effect. Another objective is to provide a cerebral nerve cell neogenesis agent that is effective in treating and/or preventing neurological disorders utilizing the substance. With the present invention, a cerebral nerve cell neogenesis agent containing a plasmalogen as an active ingredient is provided. In particular, a preferable cerebral nerve cell neogenesis agent contains, as an active ingredient, a biological tissue (preferably, an avian tissue) extracted plasmalogen mainly including an ethanolamine plasmalogen and a choline plasmalogen.
摘要翻译: 本发明的目的是提供具有脑神经细胞新生作用效果的新物质。 另一个目的是提供一种有效治疗和/或预防利用该物质的神经障碍的脑神经细胞新生物剂。 本发明提供了含有作为活性成分的浆果糖原的脑神经细胞新生成剂。 特别地,优选的脑神经细胞新生剂含有作为活性成分的生物组织(优选禽类组织),其主要包括乙醇胺丙酸纤维素原和胆碱原浆素。
-
公开(公告)号:US20130172293A1
公开(公告)日:2013-07-04
申请号:US13821407
申请日:2011-09-22
IPC分类号: A61K31/661 , C07F9/22
CPC分类号: A61K31/661 , A61K31/685 , A61K35/57 , C07F9/222
摘要: An objective of the present invention is to provide a novel method with an effect of alleviating central nervous system inflammation. The present invention provides a drug against central nervous system inflammation containing a plasmalogen. More preferably, the present invention provides a drug against central nervous system inflammation containing a plasmalogen extracted from a biological tissue (preferably an avian tissue) that mainly contains an ethanolamine plasmalogen and a choline plasmalogen.
摘要翻译: 本发明的目的是提供一种减轻中枢神经系统炎症的新方法。 本发明提供了一种抗中性神经系统炎症的药物,其含有浆细胞原子。 更优选地,本发明提供了一种针对中枢神经系统炎症的药物,其含有从主要含有乙醇胺血浆原原细胞和胆碱原纤维素原的生物组织(优选禽类组织)提取的浆果糖原。
-
公开(公告)号:US20120283223A1
公开(公告)日:2012-11-08
申请号:US13520899
申请日:2011-01-06
申请人: Masataka Ifuku , Takehiko Fujino , Shirou Mawatari , Masaaki Sugiyama , Yoshirou Kodama , Hidetaka Fuchu , Keita Yunoki
发明人: Masataka Ifuku , Takehiko Fujino , Shirou Mawatari , Masaaki Sugiyama , Yoshirou Kodama , Hidetaka Fuchu , Keita Yunoki
CPC分类号: A61K31/685 , A23L33/10 , A61K35/57 , A61K38/12
摘要: An objective of the present invention is to provide a new substance having a cerebral nerve cell neogenesis effect. Another objective is to provide a cerebral nerve cell neogenesis agent that is effective in treating and/or preventing neurological disorders utilizing the substance. With the present invention, a cerebral nerve cell neogenesis agent containing a plasmalogen as an active ingredient is provided. In particular, a preferable cerebral nerve cell neogenesis agent contains, as an active ingredient, a biological tissue (preferably, an avian tissue) extracted plasmalogen mainly including an ethanolamine plasmalogen and a choline plasmalogen.
摘要翻译: 本发明的目的是提供具有脑神经细胞新生作用效果的新物质。 另一个目的是提供一种有效治疗和/或预防利用该物质的神经障碍的脑神经细胞新生物剂。 本发明提供了含有作为活性成分的浆果糖原的脑神经细胞新生成剂。 特别地,优选的脑神经细胞新生剂含有作为活性成分的生物组织(优选禽类组织),其主要包括乙醇胺丙酸纤维素原和胆碱原浆素。
-
-